Matches in Wikidata for { <http://www.wikidata.org/entity/Q95056641> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q95056641 description "clinical trial" @default.
- Q95056641 description "ensayo clínico" @default.
- Q95056641 description "ensayu clínicu" @default.
- Q95056641 description "klinisch onderzoek" @default.
- Q95056641 description "клінічне випробування" @default.
- Q95056641 description "临床试验" @default.
- Q95056641 name "A Randomized, Controlled, Masked (Reading Center) Prospective Study of the Effectiveness and Safety of the Ocular Therapeutix Dextenza (Dexamethasone Ophthalmic Insert) 0.4 mg for the Treatment of Post-operative Inflammation and Pain in Patients" @default.
- Q95056641 name "A Randomized, Controlled, Masked (Reading Center) Prospective Study of the Effectiveness and Safety of the Ocular Therapeutix Dextenza (Dexamethasone Ophthalmic Insert) 0.4 mg for the Treatment of Post-operative Inflammation and Pain in Patients" @default.
- Q95056641 type Item @default.
- Q95056641 label "A Randomized, Controlled, Masked (Reading Center) Prospective Study of the Effectiveness and Safety of the Ocular Therapeutix Dextenza (Dexamethasone Ophthalmic Insert) 0.4 mg for the Treatment of Post-operative Inflammation and Pain in Patients" @default.
- Q95056641 label "A Randomized, Controlled, Masked (Reading Center) Prospective Study of the Effectiveness and Safety of the Ocular Therapeutix Dextenza (Dexamethasone Ophthalmic Insert) 0.4 mg for the Treatment of Post-operative Inflammation and Pain in Patients" @default.
- Q95056641 prefLabel "A Randomized, Controlled, Masked (Reading Center) Prospective Study of the Effectiveness and Safety of the Ocular Therapeutix Dextenza (Dexamethasone Ophthalmic Insert) 0.4 mg for the Treatment of Post-operative Inflammation and Pain in Patients" @default.
- Q95056641 prefLabel "A Randomized, Controlled, Masked (Reading Center) Prospective Study of the Effectiveness and Safety of the Ocular Therapeutix Dextenza (Dexamethasone Ophthalmic Insert) 0.4 mg for the Treatment of Post-operative Inflammation and Pain in Patients" @default.
- Q95056641 P1050 Q95056641-388D2373-5DC3-47ED-8B99-4F45605DB5E4 @default.
- Q95056641 P1132 Q95056641-18064FA4-C884-430D-AE85-3D4A073074AF @default.
- Q95056641 P1476 Q95056641-EC0EFB00-4A29-4C61-9794-62BF48DF7040 @default.
- Q95056641 P17 Q95056641-59F07CE0-283A-483A-92BC-8A477C92FB10 @default.
- Q95056641 P2899 Q95056641-CC0FCAAD-4D33-42A9-B452-6E68E5BA181D @default.
- Q95056641 P3098 Q95056641-D1E1BA2F-9238-4BC7-B8DA-C33FB9E4780E @default.
- Q95056641 P31 Q95056641-18BFE20B-779F-4F41-B7A1-E092498062BB @default.
- Q95056641 P4844 Q95056641-FEAF627F-57EF-42B0-80C1-BF8FB5A9BB6E @default.
- Q95056641 P580 Q95056641-03123C49-6F5E-4BA6-8D29-AD5BB44ED328 @default.
- Q95056641 P582 Q95056641-65CEB0E8-6AD0-4AB9-B214-3B3B78B708B5 @default.
- Q95056641 P6099 Q95056641-8AF7CEBD-E0F1-4290-9E12-1F1A83A2C82E @default.
- Q95056641 P8005 Q95056641-C9E8B13E-C4DE-4B1A-8C5C-A1D8CD07802C @default.
- Q95056641 P8363 Q95056641-7B94BB66-2C8D-453B-A170-2E1A8CB6DD92 @default.
- Q95056641 P859 Q95056641-F725D35C-7FAC-46A2-B6E5-5DB984466EA4 @default.
- Q95056641 P1050 Q101991 @default.
- Q95056641 P1132 "+20" @default.
- Q95056641 P1476 "A Randomized, Controlled, Masked (Reading Center) Prospective Study of the Effectiveness and Safety of the Ocular Therapeutix Dextenza (Dexamethasone Ophthalmic Insert) 0.4 mg for the Treatment of Post-operative Inflammation and Pain in Patients Who Have Undergone PhotoREfractive Keratectomy (PRK)" @default.
- Q95056641 P17 Q30 @default.
- Q95056641 P2899 "+18" @default.
- Q95056641 P3098 "NCT04396990" @default.
- Q95056641 P31 Q30612 @default.
- Q95056641 P4844 Q11426176 @default.
- Q95056641 P580 "2020-05-15T00:00:00Z" @default.
- Q95056641 P582 "2020-10-01T00:00:00Z" @default.
- Q95056641 P6099 Q42825046 @default.
- Q95056641 P8005 Q76649708 @default.
- Q95056641 P8363 Q78089383 @default.
- Q95056641 P859 Q30270657 @default.